
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.02 | 1.2987012987 | 1.54 | 1.775 | 1.5235 | 2183149 | 1.6486051 | CS |
4 | -1.49 | -48.8524590164 | 3.05 | 3.46 | 1.26 | 3582116 | 1.85984909 | CS |
12 | -12.46 | -88.8730385164 | 14.02 | 14.23 | 1.26 | 2622392 | 3.37372217 | CS |
26 | -10.49 | -87.0539419087 | 12.05 | 16.1 | 1.26 | 1454813 | 5.26297903 | CS |
52 | -13.64 | -89.7368421053 | 15.2 | 16.52 | 1.26 | 954609 | 7.13895114 | CS |
156 | -6.7 | -81.1138014528 | 8.26 | 36.64 | 1.26 | 818794 | 15.56218174 | CS |
260 | -20.94 | -93.0666666667 | 22.5 | 43.92 | 1.26 | 558376 | 16.31060674 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.